Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Thrombopoietin R

Thrombopoietin R

Brief Information

Name:Thrombopoietin receptor
Target Synonym:CD110 Antigen,THCYT2,C-MPL,CD110,MPLV,Receptors, Thrombopoietin,MPL,TPOR,Myeloproliferative leukemia protein,Myeloproliferative Leukemia Virus Oncogene,Proto-Oncogene C-Mpl,TPO-R,MPL Proto-Oncogene, Thrombopoietin Receptor,Thrombopoietin Receptor,THPOR
Number of Launched Drugs:8
Number of Drugs in Clinical Trials:12
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

THR-C52H3-SPR
 Thrombopoietin R SPR

Cynomolgus Thrombopoietin R Protein, His Tag (Cat. No. THR-C52H3) capture on NTA-Series S sensor chip can bind Human Thrombopoietin Protein, Tag Free (Cat. No. THN-H5214) with an affinity constant of 4.15 nM as determined in a SPR assay (Biacore 8K) (QC tested).

THR-M52H3-SPR
 Thrombopoietin R SPR

Mouse Thrombopoietin R Protein, His Tag (Cat. No. THR-M52H3) capture on NTA-Series S sensor chip can bind Human Thrombopoietin Protein, Tag Free with an affinity constant of 5.67 nM as determined in a SPR assay (Biacore 8K) (QC tested).

Synonym Name

MPL,C-MPL,CD110,MPLV,THCYT2,TPOR

Background

Thrombopoietin R, also known as TPO-R, is expressed predominantly on the surface of MKs, platelets, hemangioblasts, and hematopoietic stem cells (HSCs). Binding of TPO to the megakaryocyte TPO-R leads to different effects: prevention of megakaryocyte apoptosis; increased megakaryocyte number, size, and ploidy; increasing rate of megakaryocyte maturation; and internalization of the TPO/TPO-R complex. Thrombopoietin R involved in multiple signal transduction pathways, such as JAK, STAT, and MAP kinase.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Recombinant human thrombopoietin biosimilar (Biolotus) Approved Biolotus Zypotin-TPO Brazil Thrombocytopenia Biolotus 2015-01-01 Thrombocytopenia Details
Romiplostim AMP-2; AMG-531 Approved Amgen Inc Romiplate, Nplate United States Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia Amgen Inc 2008-08-22 Anemia, Aplastic; Carcinoma, Non-Small-Cell Lung; Lymphoma, Non-Hodgkin; Lymphoma; Purpura, Thrombocytopenic; Lung Neoplasms; Thrombocytopenia; Pancytopenia; Acute Radiation Syndrome; Solid tumours; Bone Marrow Failure Disorders; Multiple Myeloma; Hodgkin Disease; Myelodysplastic Syndromes; Neoplasms; Ovarian Neoplasms; Hematologic Neoplasms; Purpura, Thrombocytopenic, Idiopathic Details
Lusutrombopag S-888711 Approved Shionogi & Co Ltd Mulpleta Japan Thrombocytopenia Shionogi & Co Ltd 2015-09-28 Purpura, Thrombocytopenic, Idiopathic; Liver Diseases; Thrombocytopenia Details
Herombopag Olamine SHR-8735; SHR 8735 olamine Approved Jiangsu Hengrui Medicine Co Ltd Hengqu, 恒曲 Mainland China Anemia, Aplastic; Thrombocytopenia Jiangsu Hengrui Medicine Co Ltd 2021-06-16 Purpura, Thrombocytopenic, Idiopathic; Liver Diseases; Anemia, Aplastic; Breast Neoplasms; Thrombocytopenia; Carcinoma, Non-Small-Cell Lung Details
Romiplostim biosimilar (Qilu Pharmaceutical) QL-0911 Approved Qilu Pharmaceutical Co Ltd 瑞立升 Mainland China Thrombocytopenia Qilu Pharmaceutical Co Ltd 2024-04-02 Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia Details
Eltrombopag Diolamine SB-497115-GR; ETB-115; SB-497115 Approved Glaxosmithkline Plc Promacta/Revolade, 瑞弗兰, レボレード, 特艾升, Promacta, Revolade United States Purpura, Thrombocytopenic, Idiopathic Novartis Pharma Ag 2008-11-20 Sarcoma; Liver Diseases; Multiple Myeloma; Hemorrhage; Bone Marrow Failure Disorders; Leukemia, Megakaryoblastic, Acute; Delayed Graft Function; Anemia, Aplastic; Hepatitis B; Leukemia, Basophilic, Acute; Osteosarcoma; Leukemia, Myelomonocytic, Acute; Hepatitis C; Primary Myelofibrosis; Leukemia, Myeloid, Chronic-Phase; Thrombocytopenia; Leukemia, Myeloid, Acute; Leukemia, Monocytic, Acute; Hepatitis C, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Eosinophilic, Acute; Catheter-Related Infections; Solid tumours; HIV Infections; Leukemia; Hematologic Neoplasms; Wiskott-Aldrich Syndrome; Leukemia, Myeloid; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myelogenous, Chronic; Bone marrow transplant rejection; Hematopoietic stem cell transplantation (HSCT); Purpura, Thrombocytopenic, Idiopathic; Metabolic Dysfunction-Associated Steatotic Liver Disease; Purpura; Myelodysplastic Syndromes; Liver Cirrhosis; Blood Platelet Disorders; Fanconi Anemia; Anemia, Diamond-Blackf Details
Avatrombopag Maleate YM-477; AKR-501; AS-1670542; AKR-501-monomaleate; E-5501 Approved Astellas Pharma Inc 苏可欣, Doptelet, DOPTELET United States Thrombocytopenia; Liver Diseases Akarx Inc 2018-05-21 Purpura, Thrombocytopenic, Idiopathic; Drug-Related Side Effects and Adverse Reactions; Liver Diseases; Anemia, Aplastic; Cardiovascular Diseases; Thrombocytopenia; Lymphoma Details
Recombinant human thrombopoietin rhTPO (3SBio) Approved Shenyang Sunshine Pharmaceutical Co Ltd 特比奥, Tpiao, 特比澳, Tebiao Mainland China Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia Shenyang Sunshine Pharmaceutical Co Ltd 2005-03-10 Purpura, Thrombocytopenic, Idiopathic; Leukemia; Neutropenia; Plasmacytoma; Sepsis; Liver Cirrhosis; Liver Diseases; Multiple Myeloma; Parturition; Breast Neoplasms; Thrombocytopenia; Lymphoma; Leukemia, Myeloid, Acute; Myelodysplastic-Myeloproliferative Diseases Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Romiplostim biosimilar (Enzene Biosciences) 267639-76-9 Phase 3 Clinical Enzene Biosciences Ltd Purpura, Thrombocytopenic, Idiopathic Details
Romiplostim biosimilar (Intas Pharmaceuticals) Phase 3 Clinical Intas Biopharmaceuticals Purpura, Thrombocytopenic, Idiopathic Details
Romiplostim biosimilar(Generium) GNR-069 Phase 3 Clinical Cjsc Generium Purpura, Thrombocytopenic, Idiopathic Details
Recombinant human thrombopoietin(Peking University People's Hospital) Phase 2 Clinical Peking University People'S Hospital Purpura, Thrombocytopenic, Idiopathic; Parturition Details
Recombinant human thrombopoietin mimetics (Shandong Quangang) Phase 2 Clinical Shandong Quangang Pharmaceutical Co Ltd Purpura, Thrombocytopenic, Idiopathic Details
Pegylated thrombopoietin mimetic peptide SF-303; JNJ-26366821; RWJ-800088; PEG-TPOm Phase 1 Clinical Johnson & Johnson Details
Romiplostim biosimilar(Geropharma) GP-40141 Phase 1 Clinical Geropharm Purpura, Thrombocytopenic, Idiopathic Details
PN-20 PN20; PN-20; PJ004; PJ-004 Phase 1 Clinical Chongqing Peg-Bio Biopharm Co Ltd Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia Details
SCB-219 SCB-219-M; SCB-219; SCB-219M Phase 1 Clinical Clover Biopharmaceuticals Ltd Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia Details
Recombinant human thrombopoietin mimetic peptide-Fc fusion protein (Beijing Tide Pharmaceutical) Phase 1 Clinical Beijing Tide Pharmaceutical Co Ltd Purpura, Thrombocytopenic, Idiopathic Details
PEGylated thrombopoietin (Chongqing Paijin Bio) Phase 1 Clinical Chongqing Peg-Bio Biopharm Co Ltd Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia Details
Thrombopoietin agonist (Scripps Research) 3D9 Clinical The Scripps Research Institute Inc Thrombocytopenia Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message